Citologia • Colo útero • Guidelines

The Pap Test and Bethesda 2014

31 January, 2016
2 Comentários
por Carla Brito Lopes
2,204 visualizações
Escrito por Carla Brito Lopes

BETHESDA 2014: WHY?

The past decade has witnessed several changes in the realm of cervical cancer screening, prevention, and management. These include the increased use of liquid-based preparations; the addition of cotesting (Pap and hrHPV testing) and, more recently, primary hrHPV testing as additional screening options; further insights into HPV biology; changes in histopathology terminology; approval and implementation of prophylactic HPV vaccines; and updated guidelines for cervical cancer screening and clinical management.

Ler o artigo completo aqui.

Article first published online: 1 MAY 2015
doi:10.1002/cncy.21521

Citation: [Nayar, R. and Wilbur, D. C. (2015), The Pap test and Bethesda 2014. Cancer Cytopathology, 123: 271–281. doi: 10.1002/cncy.21521]
Copyright: © 2015 S. Karger AG, Basel.

From: US National Library of Medicine <http://www.nlm.nih.gov/> – National Institutes of Health <http://www.nih.gov/>
Disclaimer: http://www.ncbi.nlm.nih.gov/About/disclaimer.html

 

Cervix • Cytology • Guidelines

The Pap Test and Bethesda 2014

31 January, 2016
Adicionar comentário
por Carla Brito Lopes
1,020 visualizações

BETHESDA 2014: WHY?

The past decade has witnessed several changes in the realm of cervical cancer screening, prevention, and management. These include the increased use of liquid-based preparations; the addition of cotesting (Pap and hrHPV testing) and, more recently, primary hrHPV testing as additional screening options; further insights into HPV biology; changes in histopathology terminology; approval and implementation of prophylactic HPV vaccines; and updated guidelines for cervical cancer screening and clinical management.

Ler o artigo completo aqui.

Article first published online: 1 MAY 2015
doi:10.1002/cncy.21521

Citation: [Nayar, R. and Wilbur, D. C. (2015), The Pap test and Bethesda 2014. Cancer Cytopathology, 123: 271–281. doi: 10.1002/cncy.21521]
Copyright: © 2015 S. Karger AG, Basel.

From: US National Library of Medicine <http://www.nlm.nih.gov/> – National Institutes of Health <http://www.nih.gov/>
Disclaimer: http://www.ncbi.nlm.nih.gov/About/disclaimer.html

 

Também pode gostar

Sobre o autor

Carla Brito Lopes

Carla nasceu em Viana do Castelo em 1977. Licenciada em Anatomia Patológica, Citológica e Tanatológica pela Escola Superior de Tecnologia da Saúde em Lisboa. Concluiu a certificação em Laboratory Management pela ASCP (American Association of Clinical Pathology) em Setembro de 2016. Mestre em Genética Molecular e Biomedicina pela Faculdade de Ciências e Tecnologia da Universidade Nova de Lisboa. Trabalhou no Centro Hospitalar Lisboa Central entre 1998 e 2015, exercendo histopatologia e imunohistoquímica, sendo co-responsável pelo sector. Trabalha no Dr. Joaquim Chaves, Laboratório de Anatomia Patológica desde 2004 onde exerce funções de Coordenação Técnica e da Qualidade.

View all posts

2 Comments

Deixe um comentário.